|
81
|
286
|
3qcsA |
Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with 6-[2-amino-6-(4-morpholinyl)-4-pyrimidinyl]-1h-indazol-3-amine |
|
113
|
330
|
3q9xA |
Crystal structure of human ck2 alpha in complex with emodin at ph 6.5 |
|
96
|
292
|
3q53A |
Structure of phosphorylated pak1 kinase domain in complex with atp |
|
107
|
330
|
3qa0A |
Crystal structure of the apo-form of human ck2 alpha at ph 6.5 |
|
111
|
328
|
3q04A |
Crystal structure of the apo-form of human ck2 alpha at ph 8.5 |
|
267
|
949
|
3p2bA |
Crystal structure of pi3k gamma with 3-(2-morpholino-6-(pyridin-3-ylamino)pyrimidin-4-yl)phenol |
|
114
|
332
|
3q9zA |
Crystal structure of human ck2 alpha in complex with quinalizarin at ph 6.5 |
|
68
|
276
|
3q4cA |
Crystal structure of wild type braf kinase domain in complex with organometallic inhibitor cns292 |
|
65
|
263
|
3qbnA |
Structure of human aurora a in complex with a diaminopyrimidine |
|
113
|
328
|
3pzhA |
Crystal structure of maize ck2 alpha in complex with emodin at 1.92 a resolution |
|
95
|
348
|
3pupA |
Structure of glycogen synthase kinase 3 beta (gsk3b) in complex with a ruthenium octasporine ligand (os1) |
|
112
|
328
|
3q9wA |
Crystal structure of human ck2 alpha in complex with emodin at ph 8.5 |
|
107
|
327
|
3q9yA |
Crystal structure of human ck2 alpha in complex with quinalizarin at ph 8.5 |
|
108
|
361
|
3q5zA |
Crystal structure of virulent allele rop5b pseudokinase domain |
|
99
|
352
|
3q3bA |
6-amino-4-(pyrimidin-4-yl)pyridones: novel glycogen synthase kinase-3 inhibitors |
|
96
|
293
|
3q52A |
Structure of phosphorylated pak1 kinase domain |
|
104
|
327
|
3pwdA |
Crystal structure of maize ck2 in complex with nbc (z1) |
|
73
|
284
|
3qc4A |
Pdk1 in complex with dfg-out inhibitor xxx |
|
90
|
296
|
3q4zA |
Structure of unphosphorylated pak1 kinase domain |
|
110
|
363
|
3q60A |
Crystal structure of virulent allele rop5b pseudokinase domain bound to atp |
|
72
|
289
|
3pwyA |
Crystal structure of an extender (spd28345)-modified human pdk1 complex 2 |
|
73
|
274
|
3q96A |
B-raf kinase domain in complex with a tetrahydronaphthalene inhibitor |
|
19
|
100
|
3q5oA |
Crystal structure of human titin domain m10 |
|
113
|
327
|
3pvgA |
Crystal structure of z. mays ck2 alpha subunit in complex with the inhibitor 4,5,6,7-tetrabromo-1-carboxymethylbenzimidazole (k68) |
|
107
|
327
|
3pe2A |
Crystal structure of human protein kinase ck2 in complex with the inhibitor cx-5011 |
|
18
|
96
|
3ps4A |
Pdz domain from human microtubule-associated serine/threonine-protein kinase 1 |
|
0
|
14
|
3pe4B |
Structure of human o-glcnac transferase and its complex with a peptide substrate |
|
78
|
266
|
3pa4A |
X-ray crystal structure of compound 2a bound to human chk1 kinase domain |
|
68
|
276
|
3psdA |
Non-oxime pyrazole based inhibitors of b-raf kinase |
|
271
|
950
|
3oawA |
4-methylpteridineones as orally active and selective pi3k/mtor dual inhibitors |
|
73
|
267
|
3p86A |
Crystal structure of ctr1 kinase domain mutant d676n in complex with staurosporine |
|
75
|
276
|
3ppkA |
Human b-raf kinase in complex with a non-oxime furopyridine inhibitor |
|
108
|
327
|
3pe1A |
Crystal structure of human protein kinase ck2 alpha subunit in complex with the inhibitor cx-4945 |
|
72
|
263
|
3p9jA |
Aurora a kinase domain with phthalazinone pyrazole inhibitor |
|
57
|
180
|
3pm8A |
Cad domain of pff0520w, calcium dependent protein kinase |
|
1
|
14
|
3pcsE |
Structure of espg-pak2 autoinhibitory ialpha3 helix complex |
|
75
|
276
|
3ppjA |
Human b-raf kinase in complex with a furopyridine inhibitor |
|
83
|
267
|
3pa3A |
X-ray crystal structure of compound 70 bound to human chk1 kinase domain |
|
19
|
98
|
3pucA |
Atomic resolution structure of titin domain m7 |
|
73
|
271
|
3ppzA |
Crystal structure of ctr1 kinase domain in complex with staurosporine |
|
74
|
276
|
3priA |
Crystal structure of human b-raf kinase in complex with a non-oxime furopyridine inhibitor |
|
76
|
276
|
3prfA |
Crystal structure of human b-raf kinase domain in complex with a non-oxime furopyridine inhibitor |
|
80
|
269
|
3pa5A |
X-ray crystal structure of compound 1 bound to human chk1 kinase domain |
|
75
|
276
|
3psbA |
Furo[2,3-c]pyridine-based indanone oximes as potent and selective b-raf inhibitors |
|
104
|
330
|
3owlA |
Human ck2 catalytic domain in complex with a benzopyridoindole derivative inhibitor |
|
83
|
267
|
3ot8A |
X-ray crystal structure of compound 17r bound to human chk1 kinase domain |
|
64
|
276
|
3omvA |
Crystal structure of c-raf (raf-1) |
|
105
|
401
|
3p23A |
Crystal structure of the human kinase and rnase domains in complex with adp |
|
111
|
328
|
3owjA |
Human ck2 catalytic domain in complex with a pyridocarbazole derivative inhibitor |
|
114
|
325
|
3ofmA |
Structure of a human ck2alpha prime, the paralog isoform of the catalytic subunit of protein kinase ck2 from homo sapiens |
